Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.3500
+0.0050 (1.45%)
Jul 24, 2026, 3:57 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 32.31 million as of July 27, 2026. Its market cap has decreased by -54.43% in one year.
Market Cap
32.31M
Enterprise Value
26.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
ChartMarket Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 65.63M to 32.31M, a decrease of -50.78%. That is a compound annual growth rate of -7.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 32.31M | -57.91% |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 41.33M |
| Onco-Innovations | 41.10M |
| Resverlogix | 36.10M |
| Telescope Innovations | 35.55M |
| Sona Nanotech | 35.46M |
| Defence Therapeutics | 28.42M |
| Thiogenesis Therapeutics | 27.47M |